Trial intelligence / Profile preview

Prophylactic treatment of vestibular migraine with metoprolol

DRKS00005040Phase 3Terminated

Sponsor
LMU Klinikum
Start
Aug 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in vestibular migraine (VM), migraine, vertigo and 2 more comparing Metoprolol succinate with Placebo (2 arms). Started Aug 2013; status: terminated.

02

Drugs

Cormet
03

Conditions

vestibular migraine (VM)migrainevertigovestibulopathydizziness

Beyond the preview

Go deeper on DRKS00005040.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on DRKS00005040.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call